Literature DB >> 17170510

Candida albicans endophthalmitis after extracorporeal shock wave lithotripsy in a patient with liver cirrhosis.

Nobuyuki Toshikuni1, Kazuhiro Ujike, Toshihiro Yanagawa, Tatsuhito Suga, Toshinari Shimizu, Yuji Kusuda, Masayuki Okamoto, Takayoshi Ogawa, Shiro Yuasa.   

Abstract

A 69-year-old man was referred to our hospital because of hepatic failure after extracorporeal shock wave lithotripsy. The diagnosis of urinary tract infection and fungemia due to Candida albicans associated with decompensated liver cirrhosis and renal failure was made. Bilateral endogenous endophthalmitis developed during hospitalization. Candidemia, endophthalmitis and hepatorenal failure improved with intensive therapy. After discharge, endophthalmitis of the left eye relapsed and vitrectomy was performed. Clinicians should be aware that fungemia complicated by endophthalmitis can be caused by extracorporeal shock wave lithotripsy. There might be a risk of such complications among patients with liver cirrhosis in an immunocompromised state.

Entities:  

Mesh:

Year:  2006        PMID: 17170510     DOI: 10.2169/internalmedicine.45.1761

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  Acute-on-chronic Liver Failure in a Patient with Candida Endophthalmitis: A Case Report.

Authors:  Ying Cao; Ying Fan; Yanbin Wang; Xiyao Liu; Wen Xie
Journal:  J Clin Transl Hepatol       Date:  2021-03-30

2.  Candida albicans Fungaemia following Traumatic Urethral Catheterisation in a Paraplegic Patient with Diabetes Mellitus and Candiduria Treated by Caspofungin.

Authors:  Subramanian Vaidyanathan; Bakul Soni; Peter Hughes; Gordon Ramage; Leighann Sherry; Gurpreet Singh; Paul Mansour
Journal:  Case Rep Infect Dis       Date:  2013-10-08

3.  Endogenous Candida Endophthalmitis as a Rare Complication of Trans-Urethral Lithotripsy in a Healthy Woman: A Case Report

Authors:  Mohammad Shirvani; Shahla Hosseini; Mehrnoosh Maalhagh; Sahar Mohaghegh
Journal:  Turk J Ophthalmol       Date:  2019-10-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.